Antimicrobial Agents and Chemotherapy · 2010 · 68 citations · 5 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial PharmacologyAntimicrobial ResistanceMedical MicrobiologyAntibacterial PharmacologyAntibiotic ResistanceBacterial InfectionsFluoroquinolone AntibioticsResistance In Clinical IsolatesStreptococcus Species
The in vitro antibacterial activities of nemonoxacin (TG-873870), a novel nonfluorinated quinolone, against 770 clinical isolates were investigated. Nemonoxacin (tested as its malate salt, TG-875649) showed better in vitro activity than ciprofloxacin and levofloxacin against different species of staphylococci, streptococci, and enterococci, Neisseria gonorrhoeae, and Haemophilus influenzae. The in vitro activity of TG-875649 was also comparable to or better than that of moxifloxacin against these pathogens, which included ciprofloxacin-resistant, methicillin-resistant Staphylococcus aureus and levofloxacin-resistant Streptococcus pneumoniae.
5
Ling Ma, Chi-Jan Lin, Jiun-Han Chen et al. · Antimicrobial Agents and Chemotherapy · 2008 · 86 citations · Full text
Tsai‐Ling Lauderdale, L. Clifford McDonald, Yih‐Ru Shiau et al. · Diagnostic Microbiology and Infectious Disease · 2004 · 60 citations
L. Clifford McDonald, Tsai‐Ling Lauderdale, Yih‐Ru Shiau et al. · International Journal of Antimicrobial Agents · 2004 · 54 citations
Jing-Jou Yan, Po‐Ren Hsueh, Jang‐Jih Lu et al. · Antimicrobial Agents and Chemotherapy · 2006 · 52 citations · Full text